戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 SC) biology and function in the context of a humanized mouse.
2                                            A humanized mouse air-pouch model showed that intravenous
3 nhibited in vivo HIV-1 and SHIV infection in humanized mouse and macaque models, respectively, includ
4 n immunodeficiency virus (SHIV) infection in humanized mouse and macaque models, respectively, includ
5                                            A humanized mouse bearing the HLA-DR2 (DRA/DRB1*1501) prot
6 human breast tissue will be able to generate humanized mouse glands within 3 months.
7                            The hematopoietic humanized mouse (hu-mouse) model is a powerful resource
8 he early stages of acute co-infection in the humanized mouse, infection with HIV exacerbates the pro-
9                             Creation of this humanized mouse is the first step toward development of
10 esponse between mice and humans, a PPARalpha-humanized mouse line was generated in which the human PP
11                       In the future, use of "humanized" mouse lines, containing a human AHR or CYP1 a
12              Human gene expression levels in humanized mouse livers were analyzed by qPCR and Nanostr
13                                      Using a humanized mouse model (denoted Hu-mice) reconstituted wi
14  iNKT cells, we recently developed the first humanized mouse model (hCD1d-KI) with human CD1d knocked
15   Two studies in this issue of the JCI use a humanized mouse model and demonstrate that type I interf
16 t the rejection of islets of Langerhans in a humanized mouse model and examined the mechanisms involv
17 h tissue engineering, we sought to develop a humanized mouse model based on the facile and ectopic im
18 henotypically characterized a novel knock-in humanized mouse model carrying the severe, MECD-associat
19                             Furthermore, the humanized mouse model described here may prove valuable
20 f a potent and selective chemical tool and a humanized mouse model described in this report should fa
21                      Similar to humans, this humanized mouse model developed a subset of CD8alphabeta
22 ates for the first time the application of a humanized mouse model for functional analysis of human m
23      Recent advances in the development of a humanized mouse model for HIV-1 infection might provide
24  coronavirus (MERS-CoV) and development of a humanized mouse model for MERS-CoV infection, which was
25       Here, we studied bone homeostasis in a humanized mouse model for SCD.
26 is protocol describes our recently developed humanized mouse model for studying HCV and other hepatot
27 viral surveillance and the relevance of this humanized mouse model for the studies of HIV-1 pathobiol
28 hese studies demonstrate the utility of this humanized mouse model for the study of human Treg ontoge
29 ive activity of human Treg in vitro and in a humanized mouse model in vivo.
30 X chromosome dosage and sex hormones using a humanized mouse model in which male or female NOD-SCID-b
31                             We established a humanized mouse model incorporating FLT3-ligand (FLT3-L)
32                                         This humanized mouse model may be used to model the human imm
33                                          Our humanized mouse model may thus be useful for preclinical
34                     Recently, we developed a humanized mouse model of allergen-induced IgE-dependent
35 ll activation on pulmonary inflammation in a humanized mouse model of allergic airway inflammation.
36                         Importantly, using a humanized mouse model of allergic asthma, we demonstrate
37                            Furthermore, in a humanized mouse model of allergy using PBMC-engrafted NO
38                                In a chimeric humanized mouse model of allograft rejection, medial imm
39 to inhibit vascular allograft rejection in a humanized mouse model of arterial transplantation.
40                     In this study, we used a humanized mouse model of arthritis in an attempt to dete
41                                A preclinical humanized mouse model of beta thalassemia major or Coole
42 nt of betaT in the gammabeta(0)/gammabeta(A) humanized mouse model of betaT.
43 sts of anti-human GITR antibody MK-4166 in a humanized mouse model of cancer mimicked many of the eff
44                                      A novel humanized mouse model of Cooley's Anemia (CA) was genera
45                    We previously developed a humanized mouse model of DF in which mice transplanted w
46 ion will likely enhance HCV infection in the humanized mouse model of HCV infection and replication.
47                    We previously generated a humanized mouse model of HD, Hu97/18, by intercrossing B
48 n mRNA, in patient cells and in a completely humanized mouse model of HD.
49                       When introduced into a humanized mouse model of HIV-1 infection, these corecept
50 but significant decrease in GAS fitness in a humanized mouse model of impetigo; the DeltafbaA mutant
51             In our NOD/Scid IL-2Rgamma(null) humanized mouse model of leukemia, control shRNA-transdu
52         Here, we describe the development of humanized mouse model of MYC/BCL2-driven 'double-hit' ly
53                                         In a humanized mouse model of pseudoxanthoma elasticum, we in
54 ere with the development of nephropathy in a humanized mouse model of SCD.
55       We bred Kcc1(M935K) mutant mice with a humanized mouse model of sickle cell disease to directly
56                                         In a humanized mouse model of sickle cell disease, the captur
57 ation of nra leads to loss of virulence in a humanized mouse model of superficial skin infection.
58                                      Using a humanized mouse model of TSS and human cells, we herein
59             More important, in a preclinical humanized mouse model of xenogeneic graft-versus-host di
60 ed protection by IFN-alpha-treated Treg in a humanized mouse model of xenogeneic graft-versus-host di
61                             This genetically humanized mouse model opens new opportunities to dissect
62                               Here, we use a humanized mouse model overexpressing Tcf7l2, resulting i
63                                         This humanized mouse model permits in vivo evaluation of immu
64                                   Thus, this humanized mouse model permits preclinical testing of vac
65        Our establishment of this extensively humanized mouse model phenotypically and functionally re
66 f Infectious Diseases summarizes work in the humanized mouse model presented at an HIV Humanized Mous
67                                 The use of a humanized mouse model provides a way of dissecting the r
68                                         This humanized mouse model should be useful for studying immu
69 RT-PCR, lentiviral transduction, and in vivo humanized mouse model studies demonstrated that malignan
70 s well, eliminating Ag-specific T cells in a humanized mouse model system.
71 ll lymphomas in a newly developed cord blood-humanized mouse model that allows EBV-infected B cells t
72                 Here we report a genetically humanized mouse model that incorporates a luciferase rep
73                        Here we established a humanized mouse model that reproduces features of acute
74                Halper-Stromberg et al. use a humanized mouse model to demonstrate that broadly neutra
75                         We developed a novel humanized mouse model to evaluate in vivo human NK cell-
76                          Here, we utilized a humanized mouse model to recapitulate the low immunogeni
77 e recently used a newly developed cord blood-humanized mouse model to show that EBV can cooperate wit
78                           We generated a new humanized mouse model to study HLA-restricted immune res
79 er immunotherapy and provide a translational humanized mouse model to test the lifespan, safety, and
80                                      The hMB humanized mouse model underscores the synergy of MYC and
81 ociated with systemic lupus erythematosus, a humanized mouse model was examined.
82                                            A humanized mouse model was used to demonstrate that this
83 a highly sensitive and ecologically relevant humanized mouse model was used to measure superficial sk
84                                      Using a humanized mouse model we demonstrate that this missense
85 r fibrosis, we utilized a recently developed humanized mouse model with autologous human immune and l
86        We have developed a cytokine-enhanced humanized mouse model with greatly improved reconstituti
87 ration and tubulogenesis, (b) in a PPARalpha-humanized mouse model, activation of the receptor inhibi
88                             In a genetically humanized mouse model, active immunization with sE2 effi
89 to induce B cell lymphomas in the cord blood-humanized mouse model, although the simultaneous loss of
90                     Here, we have used a new humanized mouse model, in which both human fetal CD34(+)
91 hibits all preeclampsia-like features in the humanized mouse model, including new-onset proteinuria,
92 roved the immunogenicity of the H7 HA in the humanized mouse model, leading to a greater than 4-fold
93                                         In a humanized mouse model, NOTCH pathway disruption had stro
94        Ab513 mitigates thrombocytopenia in a humanized mouse model, resolves vascular leakage, reduce
95                                       In the humanized mouse model, T-cell infiltration into the sali
96                                Using a novel humanized mouse model, we demonstrated that LSEVh-LS-F r
97      Here, using a pregnane X receptor (PXR)-humanized mouse model, we found that co-treatment with R
98           By using in vitro approaches and a humanized mouse model, we provide evidence for a causal
99 is in a hematopoietic stem cell-transplanted humanized mouse model.
100 nt receptor expression and localization in a humanized mouse model.
101 habetaT cells both in vitro and in vivo in a humanized mouse model.
102 orally acquired listeriosis in a gnotobiotic humanized mouse model.
103 y mediated superior antitumor responses in a humanized mouse model.
104  strains using immunoinformatics tools and a humanized mouse model.
105 y image human immune responses in a relevant humanized mouse model.
106 ction against HCV infection in a genetically humanized mouse model.
107 a formation elicited by vascular injury in a humanized mouse model.
108 ells undergo tolerance, we developed a novel humanized mouse model.
109 at requires Fcgamma receptor engagement in a humanized mouse model.
110 rapeutic option in allergic diseases using a humanized mouse model.
111 ponse and celiac disease-like pathology in a humanized mouse model.
112 e, we aimed to corroborate our findings in a humanized mouse model.
113  than HSPCs with lower levels of ARID3a in a humanized mouse model.
114 munopathogenesis during HIV-1 infection in a humanized mouse model.
115        Additionally, we employed a chimeric "humanized" mouse model of HCV infection to demonstrate f
116                                         The 'humanized' mouse model enables strict comparison of the
117 SPA70 inhibits hPXR in human hepatocytes and humanized mouse models and enhances the chemosensitivity
118 important step forward in the development of humanized mouse models and particularly for the analysis
119                                        These humanized mouse models are becoming increasingly importa
120                                              Humanized mouse models are useful tools to understand pa
121                            However, existing humanized mouse models cannot support development of hum
122 ts associated with non-human primate models, humanized mouse models containing chimeric human livers
123                  Here, we describe the major humanized mouse models currently in use, and some recent
124 Host & Microbe, McHugh et al. (2017) develop humanized mouse models for EBV/KSHV co-infection and ide
125 arvard Center for AIDS Research symposium on humanized mouse models for HIV vaccine design.
126 d Infectious Diseases convened a workshop on humanized mouse models for immunity in Bethesda, MD, on
127 ults offer a proof of concept for the use of humanized mouse models for surrogate efficacy and histol
128                                              Humanized mouse models have become increasingly importan
129                                      Various humanized mouse models have been developed in efforts to
130                              Improvements in humanized mouse models have made them the preferred smal
131                                              Humanized mouse models have, over the past few years, se
132 nally, our findings highlight the utility of humanized mouse models in interrogating therapeutic appr
133 The low efficiency of HCV replication in the humanized mouse models is likely due to either the lack
134           In conclusion, both porcinized and humanized mouse models of heterotopic subcutaneous bronc
135 This Review summarizes the contribution that humanized mouse models of HIV infection have made to the
136                                         Thus humanized mouse models of HIV vaginal infection will all
137 lly, the drug inhibited viral replication in humanized mouse models of Rag2(-/-)gammac(-/-) with no t
138 ceptor pathway to facilitate construction of humanized mouse models on non-NOD genetic backgrounds.
139  the basis for creating increasingly complex humanized mouse models that could prove useful for study
140                                      The new humanized mouse models with a transplanted human immune
141                           The improvement of humanized mouse models with robust human immune cell rec
142                           Recent advances in humanized mouse models, in particular the humanized bone
143 nonhuman primates (NHPs), and HIV-1-infected humanized mouse models, passive transfer studies in infa
144                   Of the two current leading humanized mouse models, the hu-HSC model is created by h
145                       Using several relevant humanized mouse models, we demonstrate that TCR-transduc
146                         Using both human and humanized mouse models, we report that hyperglycemia-ind
147 ered insights into the development of future humanized mouse models.
148 ected, we used 3 different but complementary humanized mouse models.
149 wn can control rejection of human tissues in humanized mouse models.
150 ve Abs when those cells were introduced into humanized mouse models.
151 mes using a panel of knockout and transgenic humanized mouse models.
152 uct NRG or NSG mutant mice to facilitate new humanized mouse models.
153  now confirmed the findings from the cat and humanized mouse models.
154 er of limitations in the currently available humanized mouse models.
155 dy has not only provided direct evidence in "humanized" mouse models that soluble and membrane-restri
156 issue in NOD hosts during the generation of "humanized" mouse models.
157     Recently, several studies suggested that humanized mouse or transgenic mouse expressing key HCV h
158 lls were assayed from both participants in a humanized mouse outgrowth assay.
159 rum CSP inhibited liver-stage infection in a humanized mouse/P. falciparum challenge model.
160           Most significantly, when tested in humanized mouse primary hepatocytes, TA inhibits hLRH-1
161 amma chain knockout-bone marrow-liver-thymus humanized mouse provides a unique model for studying the
162                                        This "humanized" mouse represents a potentially important mode
163                      We have used a chimeric humanized mouse system to model this arteriopathy in hum
164         Using a clinically relevant chimeric humanized mouse system, we transplanted mice with human
165 osclerosis in a clinically relevant chimeric humanized mouse system.
166 el small animal model of co-infection in the humanized mouse to investigate how HIV infection disrupt
167 he humanized mouse model presented at an HIV Humanized Mouse workshop in Boston, Massachusetts, in No

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top